These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 30824634)

  • 41. Myopathy is a poor prognostic feature in systemic sclerosis: results from the Canadian Scleroderma Research Group (CSRG) cohort.
    Jung M; Bonner A; Hudson M; Baron M; Pope JE;
    Scand J Rheumatol; 2014; 43(3):217-20. PubMed ID: 24650305
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Does Systemic Sclerosis-associated Interstitial Lung Disease Burn Out? Specific Phenotypes of Disease Progression.
    Guler SA; Winstone TA; Murphy D; Hague C; Soon J; Sulaiman N; Li KH; Dunne J; Wilcox PG; Ryerson CJ
    Ann Am Thorac Soc; 2018 Dec; 15(12):1427-1433. PubMed ID: 30188737
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Interstitial lung disease in systemic sclerosis: data from the spanish scleroderma study group.
    Sánchez-Cano D; Ortego-Centeno N; Callejas JL; Fonollosa Plá V; Ríos-Fernández R; Tolosa-Vilella C; Espinosa-Garriga G; Colunga-Argüelles D; Egurbide-Arberas MV; Rubio-Rivas M; Freire M; Ríos-Blanco JJ; Trapiella-Martínez L; Rodríguez-Carballeira M; Marín-Ballvé A; Pla-Salas X; Simeón-Aznar CP
    Rheumatol Int; 2018 Mar; 38(3):363-374. PubMed ID: 29322341
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Performance of the 2013 American College of Rheumatology/European League Against Rheumatism Classification Criteria for Systemic Sclerosis (SSc) in large, well-defined cohorts of SSc and mixed connective tissue disease.
    Hoffmann-Vold AM; Gunnarsson R; Garen T; Midtvedt Ø; Molberg Ø
    J Rheumatol; 2015 Jan; 42(1):60-3. PubMed ID: 25274890
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Anti-PM-Scl antibody in patients with systemic sclerosis.
    Koschik RW; Fertig N; Lucas MR; Domsic RT; Medsger TA
    Clin Exp Rheumatol; 2012; 30(2 Suppl 71):S12-6. PubMed ID: 22261302
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Determinants of morbidity and mortality of systemic sclerosis in Canada.
    Al-Dhaher FF; Pope JE; Ouimet JM
    Semin Arthritis Rheum; 2010 Feb; 39(4):269-77. PubMed ID: 18706680
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Interstitial lung disease in systemic sclerosis: current and future treatment.
    Giacomelli R; Liakouli V; Berardicurti O; Ruscitti P; Di Benedetto P; Carubbi F; Guggino G; Di Bartolomeo S; Ciccia F; Triolo G; Cipriani P
    Rheumatol Int; 2017 Jun; 37(6):853-863. PubMed ID: 28063071
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Short-term progression of interstitial lung disease in systemic sclerosis predicts long-term survival in two independent clinical trial cohorts.
    Volkmann ER; Tashkin DP; Sim M; Li N; Goldmuntz E; Keyes-Elstein L; Pinckney A; Furst DE; Clements PJ; Khanna D; Steen V; Schraufnagel DE; Arami S; Hsu V; Roth MD; Elashoff RM; Sullivan KM;
    Ann Rheum Dis; 2019 Jan; 78(1):122-130. PubMed ID: 30409830
    [TBL] [Abstract][Full Text] [Related]  

  • 49. 2013 classification criteria for systemic sclerosis: an American College of Rheumatology/European League against Rheumatism collaborative initiative.
    van den Hoogen F; Khanna D; Fransen J; Johnson SR; Baron M; Tyndall A; Matucci-Cerinic M; Naden RP; Medsger TA; Carreira PE; Riemekasten G; Clements PJ; Denton CP; Distler O; Allanore Y; Furst DE; Gabrielli A; Mayes MD; van Laar JM; Seibold JR; Czirjak L; Steen VD; Inanc M; Kowal-Bielecka O; Müller-Ladner U; Valentini G; Veale DJ; Vonk MC; Walker UA; Chung L; Collier DH; Csuka ME; Fessler BJ; Guiducci S; Herrick A; Hsu VM; Jimenez S; Kahaleh B; Merkel PA; Sierakowski S; Silver RM; Simms RW; Varga J; Pope JE
    Arthritis Rheum; 2013 Nov; 65(11):2737-47. PubMed ID: 24122180
    [TBL] [Abstract][Full Text] [Related]  

  • 50. 2013 American College of Rheumatology/European League against rheumatism classification criteria for systemic sclerosis outperform the 1980 criteria: data from the Canadian Scleroderma Research Group.
    Alhajeri H; Hudson M; Fritzler M; Pope J; Tatibouet S; Markland J; Robinson D; Jones N; Khalidi N; Docherty P; Kaminska E; Masetto A; Sutton E; Mathieu JP; Ligier S; Grodzicky T; LeClercq S; Thorne C; Gyger G; Smith D; Fortin PR; Larché M; Baron M
    Arthritis Care Res (Hoboken); 2015 Apr; 67(4):582-7. PubMed ID: 25233870
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Survival rate, causes of death, and risk factors in systemic sclerosis: a large cohort study.
    Li X; Qian YQ; Liu N; Mu R; Zuo Y; Wang GC; Jia Y; Li ZG
    Clin Rheumatol; 2018 Nov; 37(11):3051-3056. PubMed ID: 30225558
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Outcomes in systemic sclerosis-related lung disease after lung transplantation.
    Sottile PD; Iturbe D; Katsumoto TR; Connolly MK; Collard HR; Leard LA; Hays S; Golden JA; Hoopes C; Kukreja J; Singer JP
    Transplantation; 2013 Apr; 95(7):975-80. PubMed ID: 23545509
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Survival after lung transplantation in systemic sclerosis. A systematic review.
    Khan IY; Singer LG; de Perrot M; Granton JT; Keshavjee S; Chau C; Kron A; Johnson SR
    Respir Med; 2013 Dec; 107(12):2081-7. PubMed ID: 24113572
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Venous Thromboembolism in Systemic Sclerosis: Prevalence, Risk Factors, and Effect on Survival.
    Johnson SR; Hakami N; Ahmad Z; Wijeysundera DN
    J Rheumatol; 2018 Jul; 45(7):942-946. PubMed ID: 29657152
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Prevalence, incidence, survival, and disease characteristics of systemic sclerosis in a large US population.
    Mayes MD; Lacey JV; Beebe-Dimmer J; Gillespie BW; Cooper B; Laing TJ; Schottenfeld D
    Arthritis Rheum; 2003 Aug; 48(8):2246-55. PubMed ID: 12905479
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Prevalence and progression of diabetic nephropathy in South Asian, white European and African Caribbean people with type 2 diabetes: A systematic review and meta-analysis.
    Jadawji C; Crasto W; Gillies C; Kar D; Davies MJ; Khunti K; Seidu S
    Diabetes Obes Metab; 2019 Mar; 21(3):658-673. PubMed ID: 30407709
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Progressive systemic scleroderma--prognosis determining involvement of internal organ systems].
    Mittag M; Haustein UF
    Hautarzt; 1998 Jul; 49(7):545-51. PubMed ID: 9715381
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effects of white European, African Caribbean and South Asian ethnicity on homocysteine levels in patients with systolic heart failure.
    Sosin MD; Patel JV; Bhatia GS; Hughes EA; Davis RC; Lip GY
    Int J Cardiol; 2008 Sep; 129(1):69-75. PubMed ID: 17719103
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Sex disparities in systemic sclerosis-associated pulmonary arterial hypertension: a cohort study.
    Pasarikovski CR; Granton JT; Roos AM; Sadeghi S; Kron AT; Thenganatt J; Moric J; Chau C; Johnson SR
    Arthritis Res Ther; 2016 Jan; 18():30. PubMed ID: 26819137
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Pulmonary survival study in 91 patients with systemic sclerosis.
    Poormoghim H; Lakeh MM; Mohammadipour M; Talehy-Moineddin S; Sodagari F
    Rheumatol Int; 2011 Dec; 31(12):1577-82. PubMed ID: 20496069
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.